维普期刊资源整合服务平台（V6.5）

229篇 您的检索式：作者名="Becker MA"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Hyperuricemia and associated disease 显示文摘	Becker MA Jolly M	2006	Rheum Dis Clin North Am2006，32，2：	1
2	Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘	Becker MA Schumacher HR Wortamann RL	2005	N Engl J Med2005，353，：	1
3	Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘	Becker MA Schumacher HR Wortmann RL	2005	NEnglJMed2005，353，23：	1
4	The urate - lowering efficacy and safety of febuxostat in the treatment of the hy- peruricemia of gout :The CONFIRMS trial 显示文摘	Becker MA Schumacher HR Espinoza LR	2010	Arthritis Res and T- her2010，12，：	1
5	The epidemiology and genetics of pituitary adenomas显示文摘	Daly AF Tichomirowa MA Beckers A	2009	Best Pract Res Clin Endocrinol Metab2009，23，5：	1
6	Febuxostat compared with allopurinol in patients with hyperuricemia and gout 显示文摘	Becker MA Schumacher HR Wortmann RL	2005	New En J Med2005，353，：	1
7	The epidemiology and genetics of pituitary adenomas 显示文摘	Daly AF Tichomirowa MA Beckers A	2009	Best Pract Res Clin Endocrinol Metab2009，23，5：	1
8	Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells显示文摘	Becker PM Verin AD Booth MA	2001	Am J Physiol Lung Cell Mol Physiol2001，281，：	1
9	Prevalence ofcognitive disorders differs as a function of age in HIVvirus infection 显示文摘	Becker JT Lopez OL Dew MA	2004	AIDS2004，181，：	1
10	Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout :A 28 - week, phase Ⅲ, ran- domized, double - blind, parallel - group trial 显示文摘	Schumacher JRHR Becker MA Wortmann RL	2008	Arthritis Care Res2008，59，：	1
11	Hyperuricemia and associated disease显示文摘	Becker MA Jolly M	2006	Rheum Dis Clin North Am2006，32，2：	1
12	Changes in cognitive functioning following treatment of late life depression显示文摘	Butters MA Becker JT Nebes RD	2000	Am J Psyohiatry2000，157，2：	1
13	Hyperuricemia and associated disease 显示文摘	Becker MA Jolly M	2006	Rheum Dis Clin North Am2006，32，2：	1
14	A biomeehanieal study of Jefferson fracture显示文摘	Becker MA Heggeness MH Doherty BJ	1998	Spine1998，23，18：	1
15	Reduction ofplasma urate levels following treatment with multiple doses of pe-gloticase(polyethylene glycol-conjugated uricase)in patientswith treatment-failure gout:results of a phase II randomized study显示文摘	SUNDY JS BECKER MA BARAF HS	2008	Arthritis Rheum2008，58，9：	1
16	Quality of life and disability in patients with treatment-failure gout 显示文摘	BECKER MA SCHUMACHER HR BENJAMIN KL	2009	J Rheumatol2009，36，5：	1
17	Efficacy andsafety of intravenous(IV)pegloticase(PGL)in subjects withtreatment failure gout(TFG):Phase 3 results from GOUT1 andGOUT2显示文摘	SUNDY JS BARAF HS BECKER MA	2008	Arthritis Rheum2008，58，9：	1
18	Hyperuricemia and associated diseases显示文摘	Becker MA Jolly M	2006	RheumDis Clin North Am2006，32，2：	1
19	Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘	Becker MA Schumacher HR Jr Wortman RL	2005	N Engl J Med2005，353，23：	1
20	Febuxostat (TMX-67), a novel, nonpurine, selective inhibitor of xanthine oxidase, is safe and decreasesserum urate in healthy volunteers 显示文摘	Becker MA Kisicki J Khosravan R	2004	Nucleosides Nucleotides Nucleic Acids2004，23，8：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示